Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer

NCT03129074 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped sponsor decision

Conditions

Advanced or Metastatic Biliary Tract Cancer

Interventions

DRUG: Varlitinib
DRUG: Capecitabine

Sponsor

ASLAN Pharmaceuticals